NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Three-Dimensional Engineered High Fidelity Normal Human Lung Tissue-Like Assemblies (TLA) as Targets for Human Respiratory Virus InfectionsUnlike traditional two-dimensional (2D) cell cultures, three-dimensional (3D) tissue-like assemblies (TLA) (Goodwin et aI, 1992, 1993, 2000 and Nickerson et aI. , 2001,2002) offer high organ fidelity with the potential to emulate the infective dynamics of viruses and bacteria in vivo. Thus, utilizing NASA micro gravity Rotating Wall Vessel (RWV) technology, in vitro human broncho-epithelial (HBE) TLAs were engineered to mimic in vivo tissue for study of human respiratory viruses. These 3D HBE TLAs were propagated from a human broncho-tracheal cell line with a mesenchymal component (HBTC) as the foundation matrix and either an adult human broncho-epithelial cell (BEAS-2B) or human neonatal epithelial cell (16HBE140-) as the overlying element. Resulting TLAs share several characteristic features with in vivo human respiratory epithelium including tight junctions, desmosomes and cilia (SEM, TEM). The presence of epithelium and specific lung epithelium markers furthers the contention that these HBE cells differentiate into TLAs paralleling in vivo tissues. A time course of infection of these 3D HBE TLAs with human respiratory syncytial virus (hRSV) wild type A2 strain, indicates that virus replication and virus budding are supported and manifested by increasing virus titer and detection of membrane-bound F and G glycoproteins. Infected 3D HBE TLAs remain intact for up to 12 days compared to infected 2D cultures that are destroyed in 2-3 days. Infected cells show an increased vacuolation and cellular destruction (by transmission electron microscopy) by day 9; whereas, uninfected cells remain robust and morphologically intact. Therefore, the 3D HBE TLAs mimic aspects of human respiratory epithelium providing a unique opportunity to analyze, for the first time, simulated in vivo viral infection independent of host immune response.
Document ID
20110011283
Acquisition Source
Johnson Space Center
Document Type
Presentation
Authors
Goodwin, T. J.
(NASA Johnson Space Center Houston, TX, United States)
Deatly, A. M.
(Wyeth Ayerst Research Pearl River, NY, United States)
Suderman, M. T.
(NASA Johnson Space Center Houston, TX, United States)
Lin, Y.-H.
(Wyeth Ayerst Research Pearl River, NY, United States)
Chen, W.
(Wyeth Ayerst Research Pearl River, NY, United States)
Gupta, C. K.
(Wyeth Ayerst Research Pearl River, NY, United States)
Randolph, V. B.
(Wyeth Ayerst Research Pearl River, NY, United States)
Udem, S. A.
(Wyeth Ayerst Research Pearl River, NY, United States)
Date Acquired
August 25, 2013
Publication Date
July 12, 2003
Subject Category
Life Sciences (General)
Report/Patent Number
JSC-CN-68227
Meeting Information
Meeting: 22nd Annual Meeting of American Society for Virology
Location: Davis, CA
Country: United States
Start Date: July 12, 2003
End Date: July 16, 2003
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available